65,437 trials
Barrett's Esophagus
Primary: Mean Ki67 Expression — 35.6; 307.8 cells/mm2
Melanoma
Primary: Number of Participants Who Completed SSE at Specified Time Points — 217; 242; 475; 238 Participants — p=<0.001
Dental Pain
Primary: Sum Pain Intensity Difference Scores — -2.4292; -68.0778; -68.3533; -93.3645 score on a scale
Atopic Dermatitis
Primary: Percentage of Participants With Success in the Overall Investigator's Global Assessment of Disease Severity (IGA) Score at Week 4 [Using Non-responder Imputation or Last…
Airway Obstruction
Primary: Number of Paramedics/Combat Medics Who Accurately Identified the Cricothyroid Membrane on Standardized Patients of Different Sizes — 6; 7; NA; 8 Participants
Lower Back Pain
Primary: Immediate Pain Measured by Numeric Pain Rating Scale (NPRS) — 4.89; 5.18 score on a scale
Postoperative Pain
Primary: Summed Pain Intensity (SPI) Between Group A and Group C — 153.08; 267.51 score on a scale — p=<0.001
Pain
Primary: Postoperative Morphine Consumption — 59; 28 Miligram
Rheumatoid Arthritis · Inflammatory Arthritis · Arthritis
Primary: GMFR (Geometric Mean Fold Rise ) in Varicella Zoster Virus (VZV) Glycoprotein Enzyme-linked Immunosorbent Assay (gpELISA) Immunoglobulin G (IgG) Levels From Baseline at…
Intestinal Microbiota and Barrier Function
Primary: Change in Microbiota, as Measured by Change in Microbiota Composition, Including Presence of B. Adolescentis BD1 and B. Animalis Supsp Lactis BB-12 — 7.9; 9.1; 8.8; 6.0…
Rhinoplasty · Non-steroidal Ant Inflammatory Drugs · Opioid Use
Primary: Average Pain Score — 2.54; 3.14 score on a scale
Refractive Errors · Myopia
Primary: Distance Visual Acuity (VA) With Study Lenses — -0.13; -0.12 logMAR
Knee Osteoarthritis
Primary: Visual Analog Pain Score — 2.49; 3.25 score on a scale
Triple-negative Metastatic Breast Cancer
Primary: Objective Response Rate — 26 percentage of participants
Non-Small Cell Lung Cancer · Leptomeningeal Metastases · Brain Metastases
Primary: Best Overall Response Rate (ORR) of Subjects With BM — 15.4; 100; 31.3; 0 Percentage of participants (%)